Skip to main content

Shared from the PPN World agenda

USUnited StatesHealthtentative

PDUFA date: Mim8 (Novo Nordisk, hemophilia A) and brepocitinib (Pfizer/Priovant, dermatomyositis)

FDA decisions on two candidates with strong commercial potential at quarter's end.

News
2/5
Markets
4/5
Overall
3/5
XLinkedInWhatsAppFacebook

Also on Wed, Sep 30

The whole day →The whole week →

Know what's coming. Read it the second it lands.

PPN World puts the world's scheduled set pieces — central banks, data, elections, summits — beside every press release from 1,400+ feeds in 190+ countries, live. Filter by country, export to your calendar, get alerted.

Cancel anytime · CA$99/month

Open the agenda in PPN World →About the World Agenda →

Shared via PPN World — real-time press release intelligence.